Consuming excessive amounts of dietary salt is widely recognized as a primary driver of hypertension, placing a massive burden on global public health systems. However, growing scientific evidence suggests that the toll of a high-salt diet extends far beyond the cardiovascular system, actively interfering with cognitive functions, memory retention, and emotional well-being. Because modern diets frequently exceed recommended sodium levels, researchers are urgently seeking interventions to mitigate the physiological damage caused by excess salt.
Now, a team of researchers in Japan has identified a promising candidate in LPC70, a specialized compound derived from soy. Building on previous research demonstrating that this unique ingredient could alleviate high-salt-diet-induced hypertension and cognitive impairments in mice, a new study takes a comprehensive look at the underlying mechanisms. The findings reveal that the compound actively influences critical chemical signaling pathways within both the brain and the kidneys, offering a localized defense against the widespread systemic impacts of excessive sodium consumption.
How a Soy Compound May Counter the Effects of Excess Salt
The investigation centers heavily on prostaglandins, a group of powerful signaling molecules synthesized from arachidonic acid, a vital fatty acid. These substances operate much like local hormones, exercising regulatory control over essential physiological functions throughout the entire body.
Within the cardiovascular system, prostaglandins play a pivotal role in managing blood pressure by carefully balancing the dilation and constriction of blood vessels. Their functions within the central nervous system, however, are significantly more complex. Depending entirely on which specific receptors they bind to and activate, these signaling molecules can trigger neuroprotective pathways that safeguard nerve cells or, conversely, drive harmful inflammatory processes that compromise memory, cognitive processing, and emotional regulation.
LPC70 is a specialized form of soy lysolecithin in which lysophosphatidylcholine accounts for more than 70 percent of the total phospholipid content. Although earlier laboratory experiments confirmed that administering LPC70 could ease salt-related hypertension and cognitive difficulties, the exact molecular mechanisms responsible for these protective effects remained poorly understood, particularly regarding how the compound modulates prostaglandin signaling cascades.
To resolve these questions, a dedicated research team embarked on a detailed investigation into how LPC70 alters these pathways in subjects consuming high-salt diets. The team was led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close collaboration with Dr. Kazuhiro Kagotani.
Dr. Kubota, who served as the study’s first author, was instrumental in executing the experimental phases. He rigorously assessed blood pressure fluctuations, tracked behavioral alterations, and analyzed the molecular activity tied to prostaglandins. His meticulous work helped clarify how LPC70 exerts distinct, organ-specific effects in the vital tissues responsible for salt-related cardiovascular and cognitive dysfunction.
The leadership behind the project spans several esteemed academic and industrial institutions. Prof. Mouri and Dr. Kubota are affiliated with the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, as well as the International Center for Brain Science at Fujita Health University in Japan. Meanwhile, Dr. Kagotani brings industry expertise, maintaining affiliations with Tsuji Oil Mills Co., Ltd. in Japan and the Tsuji Health and Beauty Science Laboratory at Mie University.
The comprehensive findings were released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," noted Prof. Mouri, discussing the impetus behind the investigation. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd, a company that develops naturally derived food ingredients," he added.
Soy Compound Improves Blood Pressure and Memory in Mice
To test the efficacy of the compound, the researchers evaluated mice subjected to a high-salt diet. As anticipated, the animals developed significantly elevated blood pressure compared to control groups consuming normal diets. However, the negative physiological consequences extended far beyond cardiovascular strain.
Behavioral evaluations revealed that the high-salt-fed mice experienced marked declines in social interaction. Furthermore, they exhibited severe difficulties in recognizing objects they had encountered previously, pointing directly to impaired recognition memory. Interestingly, general locomotor activity and baseline anxiety-like behaviors remained largely unchanged. This specific pattern strongly indicates that excessive salt intake selectively disrupts higher-order cognitive and social processing rather than inducing generalized, widespread behavioral impairment across all domains.
When the research team supplemented the diets of these mice with LPC70, a dramatic shift occurred. Several of the most damaging effects of the high-salt diet were successfully mitigated. Blood pressure levels improved toward a healthy baseline, and the treated mice demonstrated noticeably superior performance during rigorous evaluations of social interaction and object recognition memory.
These encouraging macroscopic improvements prompted the scientific team to look closer at the molecular environment inside the animals’ kidneys and brains, seeking to uncover the precise biological drivers of the recovery.
Different Protective Effects in the Kidneys and Brain
Upon analyzing the kidneys, the researchers discovered that a high-salt diet significantly upregulated the expression of two key components involved in prostaglandin signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these biological factors are strongly implicated in the pathogenesis of salt-sensitive hypertension.
The administration of LPC70 successfully suppressed these salt-induced elevations. This indicated that the soy-derived compound helps correct aberrant signaling pathways in the kidneys that would otherwise interfere with the body’s natural ability to regulate blood pressure effectively.
In contrast, the prefrontal cortex—a brain region critically responsible for executive function, working memory, and social behavior—exhibited a markedly different response to the high-salt regimen.
Excess salt consumption led to a distinct reduction in the expression of the PGD2 receptor DP1, a protein heavily involved in neuroprotective and anti-inflammatory signaling pathways within the central nervous system. Remarkably, supplementing the diet with LPC70 restored the expression levels of this beneficial receptor. Crucially, the compound achieved this without altering DP2, a separate receptor subtype that is frequently associated with neuroinflammatory processes and potential cellular damage.
This functional distinction is vital for understanding the therapeutic potential of the compound. It demonstrates that LPC70 does not simply upregulate or suppress all prostaglandin activity indiscriminately. Instead, it selectively champions signaling pathways that offer localized protection to neural tissue, providing a plausible mechanistic explanation for the preserved memory and enhanced social behavior observed in the treated subjects.
A Surprising Change in Chemical Signaling
In addition to receptor-level changes, the investigation uncovered an unexpected metabolic shift involving arachidonic acid, the foundational fatty acid utilized by the mammalian body to synthesize prostaglandins.
Mice maintained on a high-salt diet paradoxically displayed lower levels of circulating arachidonic acid. Yet, when these same animals received LPC70 supplementation, the biological levels of downstream prostaglandins derived from this fatty acid—including both PGE2 and PGD2—actually increased.
This seemingly contradictory biochemical result suggests that LPC70 may enhance metabolic efficiency, enabling the body to utilize available pools of arachidonic acid more effectively for prostaglandin synthesis even under the stressful physiological conditions imposed by a high-salt diet.
Taken as a whole, the data reveal a highly coordinated yet remarkably selective response. In the renal system, LPC70 appears to downregulate signaling cascades linked to hypertension. In the cerebral cortex, it selectively restores signaling pathways associated with neural protection and inflammation defense. Consequently, the compound’s therapeutic profile is dictated by both the target organ and the specific prostaglandin receptors undergoing regulation.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The cumulative results suggest that LPC70 holds genuine potential to be developed into a specialized functional food ingredient designed to buffer humans against some of the more deleterious health consequences of excessive dietary sodium.
Its proven capacity to concurrently ameliorate high blood pressure and cognitive deficits in an animal model raises the exciting possibility that similar nutritional interventions could support both cardiovascular and neurological health in human populations burdened by high-sodium diets.
Nevertheless, researchers emphasize that these insights are derived entirely from preclinical animal models. Extensive clinical trials involving human subjects will be necessary to establish whether parallel physiological benefits can be replicated safely in people.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri.
The findings contribute a clearer, mechanistically grounded picture of how a naturally occurring soy-derived compound can interact with the body’s complex signaling networks to alter responses to excessive salt, opening promising avenues for nutritional strategies aimed at preserving long-term human health.
The research was made possible through financial backing from several prestigious sources, including Grants-in-Aid for Scientific Research provided by the Japan Society for the Promotion of Science under reference numbers 20K07931, 22K07606, 22K11891, and 23H02843.
Additional support was furnished by the Fujita Mind-Brain Research & Innovation Center for Drug Generation through Japan’s Peak Research Universities Program under grant JPJS00420240019, alongside the Japan Science and Technology Agency FOREST Program under grant reference JPMJFR215H. Further funding, grants, and operational support were provided by Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.